Trials

Study area Active Centers Enrolled Patients
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Abacus 2 0 0 0 0 0 0 0 0 0 0 0 0 0 8 11 13
Adiuvo 43 0 0 0 0 1 3 6 19 31 43 51 63 73 79 91 91
ASCT-RT 22 23 58 95 136 186 251 292 343 393 437 485 486 487 489 489 489
Audit Ovaio 7 0 0 0 0 0 0 0 0 0 0 0 0 0 265 555 646
BonEnza 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16 18
CCANDY 6 0 0 0 0 0 0 0 0 0 0 60 137 192 218 218 218
COROP 1 0 0 0 0 10 466 466 466 466 466 466 466 466 466 466 466
DRTST 4 0 0 0 0 0 0 0 0 0 0 0 0 0 2 37 41
EARLY 9 0 0 0 0 0 0 0 0 0 0 0 0 0 1 11 13
EndoRing 7 0 0 0 0 0 0 0 0 0 0 0 1 295 951 951 951
ENOAPA 9 0 0 0 0 0 0 0 0 4 36 71 102 137 170 210 214
EPoS 3 0 0 0 0 0 0 0 0 1 1 1 1 1 7 50 53
EUDRACT 2004-003495-11 21 0 3 18 32 48 62 63 65 65 65 65 65 65 65 65 65
FIL DLCL10 27 0 0 0 0 0 0 0 0 11 24 43 65 88 112 112 112
FIL FLAZ12 49 0 0 0 0 0 0 0 0 9 32 66 89 113 135 154 155
FIL PanAL10 17 0 0 0 0 0 0 0 7 21 33 35 35 35 35 35 35
FIL R2-B 34 0 0 0 0 0 0 0 0 16 42 42 42 42 42 42 42
FIL RBAC500 43 0 0 0 0 0 0 0 0 18 51 57 57 57 57 57 57
FUCSAM 26 0 0 0 0 0 0 0 0 0 9 386 928 1556 1836 1836 1836
FUSE 7 0 0 0 0 0 0 0 0 0 0 287 687 687 687 687 687
GIMURELL LLC 13 0 4 17 29 34 35 35 35 35 35 35 35 35 35 35 35
GIMURELL REAL07 23 0 0 0 0 9 18 39 66 66 66 66 66 66 66 66 66
GIMURELL ZETAL07 12 0 0 0 1 5 21 25 25 25 25 25 25 25 25 25 25
IIL BRIL06 22 0 0 3 36 53 53 53 53 53 53 53 53 53 53 53 53
IIL DLCL04 77 0 0 47 126 239 333 399 399 399 399 399 399 399 399 399 399
IIL FLE09 35 0 0 0 0 0 3 27 80 80 80 80 80 80 80 80 80
IIL HD0801 30 0 0 0 0 12 98 222 344 475 520 520 520 520 520 520 520
IIL HD0802 38 0 0 0 0 0 24 88 146 194 228 255 265 265 265 265 265
IIL HD0803 35 0 0 0 0 0 0 2 26 49 50 50 50 50 50 50 50
IIL LEN-DEX MCL07 14 0 0 0 0 10 33 33 33 33 33 33 33 33 33 33 33
IIL MCL0208 52 0 0 0 0 0 0 19 70 133 201 265 300 300 300 300 300
Itavision 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 793 1007
LCI ADR 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 350 555
MDS ATO-AISSM02A 13 0 5 21 33 44 44 44 44 44 44 44 44 44 44 44 44
MDS DECI2009-AISSM06 19 0 0 0 0 0 0 19 43 43 43 43 43 43 43 43 43
MDS EPO2006-AISSM04 9 0 0 0 2 32 55 71 71 71 71 71 71 71 71 71 71
MDS Registro 106 909 1036 1184 1290 1434 1613 1933 2420 3022 3571 4051 4428 4699 4963 5163 5252
MWA vs SABR 2 0 0 0 0 0 0 0 0 0 0 0 0 3 4 4 4
NAC-GC-01 4 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 2
Osteo-REC 10 0 0 0 0 0 0 0 0 2 5 8 8 8 8 8 8
Osteo-REC 2015 9 0 0 0 0 0 0 0 0 0 0 0 0 3 5 7 7
PON-PC-02 28 1 1 1 1 1 1 12 69 140 183 199 199 199 199 199 199
Registro LMC GIMEMA 68 0 0 0 0 1 1 1 1 13 42 100 480 1194 1688 2047 2071
Studio GDM 1 0 0 0 0 0 23 70 177 200 200 200 200 200 200 200 200
Studio H2WL 1 0 0 0 0 0 0 0 0 0 0 0 69 120 120 120 120
Studio Resveratrolo 1 0 0 0 0 0 0 0 0 0 32 125 192 192 192 192 192
Studio TOTEM 44 0 0 0 0 5 107 329 547 775 987 1150 1349 1557 1775 1887 1887
Study ML17638: Rituximab 33 19 98 158 235 235 235 235 235 235 235 235 235 235 235 235 235
TRANSLATE colon-retto 2 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 4
TRANSLATE mammella 2 0 0 0 0 0 0 0 0 0 0 0 0 5 6 7 7
TRANSLATE prostata 2 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3
TRANSLATE rene 2 0 0 0 0 0 0 0 0 0 0 0 0 0 2 3 3